<article>Singapore-based global precision engineering and technology group Accuron Technologies Ltd on Thursday announced that it will spin out its medtech business, Accuron MedTech Group.</article>

Singapore-based global precision engineering and technology group Accuron Technologies Ltd on Thursday announced that it will spin out its medtech business, Accuron MedTech Group.
Accuron MedTech is said to be the largest medical device business in Southeast Asia, with a core focus on urology devices and services.
As a result of the spin-out, it will be established as a vertically integrated urology business and will be directly owned by Temasek Holdings.
According to Accuron Technologies, itself a wholly-owned subsidiary of Temasek, the move will allow Accuron MedTech&#8217;s management team to better focus on global medtech growth and investment opportunities. The spin-out process will be completed by March.
“Accuron MedTech has been managed as an independent division of Accuron Technologies for some time now. The spin out will enable Accuron MedTech to be more agile in managing its operations, putting it on a stronger platform for sustained growth and technology commercialisation.
&#8220;The move will also allow Accuron Technologies Limited to focus its resources to pursue opportunities in the growing Aerospace and Industrial businesses,&#8221; said Accuron Technologies chairman Philip Yeo.
Accuron MedTech claims to have grown its revenue by more than 30 per cent over the last three years through the launch of new products and more than 10 merger and acquisition transactions.
It has operations in the US, Germany, Spain, France, Italy, China, Malaysia and Japan. Accuron MedTech also makes strategic investments in medical technology companies to strengthen its portfolio of healthcare solutions for customers around the world.
Last April, it <a href="https://www.dealstreetasia.com/stories/temasek-backed-accuron-divests-veredus-labs-to-japans-sekisui-medical-95434/">divested its stake</a> in molecular detection tests provider Veredus Laboratories for an undisclosed sum to Japan-based diagnostics company SEKISUI MEDICAL. The Singapore company had acquired a controlling stake in Veredus in 2014.
Also Read:
<a style="color: #ff0000;" href="https://www.dealstreetasia.com/stories/temasek-unit-leads-s2-6-pre-series-singaporean-startup-advent-access-88284/">Temasek’s Accuron MedTech leads $1.9m pre-series A in Singapore startup Advent Access</a>
<a style="color: #ff0000;" href="https://www.dealstreetasia.com/stories/46352-46352/">Singapore: Temasek-owned Accuron picks majority in Aurum Healthcare</a>

Accuron MedTech is said to be the largest medical device business in Southeast Asia, with a core focus on urology devices and services.

Temasek-owned Accuron Technologies spins out medtech business

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Temasek-owned Accuron Technologies spins out medtech business

Start your deal-making journey now!

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief